Literature DB >> 28621764

Neuroimmunology: B cells and variant BAFF in autoimmune disease.

Manuel Comabella1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28621764     DOI： 10.1038/nrneurol.2017.87

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation.

Authors:  Barbara Serafini; Martina Severa; Sandra Columba-Cabezas; Barbara Rosicarelli; Caterina Veroni; Giuseppe Chiappetta; Roberta Magliozzi; Richard Reynolds; Eliana Marina Coccia; Francesca Aloisi
Journal:  J Neuropathol Exp Neurol       Date:  2010-07       Impact factor: 3.685

Review 2.  B-cell targeted therapies in human autoimmune diseases: an updated perspective.

Authors:  Michael J Townsend; John G Monroe; Andrew C Chan
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  Epidemiology of multiple sclerosis in south-western Sardinia.

Authors:  Eleonora Cocco; Claudia Sardu; Rita Massa; Elena Mamusa; Luigina Musu; Paola Ferrigno; Maurizio Melis; Cristina Montomoli; Virginia Ferretti; Giancarlo Coghe; Giuseppe Fenu; Jessica Frau; Lorena Lorefice; Nicola Carboni; Paolo Contu; Maria G Marrosu
Journal:  Mult Scler       Date:  2011-06-07       Impact factor: 6.312

4.  Overexpression of the Cytokine BAFF and Autoimmunity Risk.

Authors:  Maristella Steri; Valeria Orrù; M Laura Idda; Maristella Pitzalis; Mauro Pala; Ilenia Zara; Carlo Sidore; Valeria Faà; Matteo Floris; Manila Deiana; Isadora Asunis; Eleonora Porcu; Antonella Mulas; Maria G Piras; Monia Lobina; Sandra Lai; Mara Marongiu; Valentina Serra; Michele Marongiu; Gabriella Sole; Fabio Busonero; Andrea Maschio; Roberto Cusano; Gianmauro Cuccuru; Francesca Deidda; Fausto Poddie; Gabriele Farina; Mariano Dei; Francesca Virdis; Stefania Olla; Maria A Satta; Mario Pani; Alessandro Delitala; Eleonora Cocco; Jessica Frau; Giancarlo Coghe; Lorena Lorefice; Giuseppe Fenu; Paola Ferrigno; Maria Ban; Nadia Barizzone; Maurizio Leone; Franca R Guerini; Matteo Piga; Davide Firinu; Ingrid Kockum; Izaura Lima Bomfim; Tomas Olsson; Lars Alfredsson; Ana Suarez; Patricia E Carreira; Maria J Castillo-Palma; Joseph H Marcus; Mauro Congia; Andrea Angius; Maurizio Melis; Antonio Gonzalez; Marta E Alarcón Riquelme; Berta M da Silva; Maurizio Marchini; Maria G Danieli; Stefano Del Giacco; Alessandro Mathieu; Antonello Pani; Stephen B Montgomery; Giulio Rosati; Jan Hillert; Stephen Sawcer; Sandra D'Alfonso; John A Todd; John Novembre; Gonçalo R Abecasis; Michael B Whalen; Maria G Marrosu; Alessandra Meloni; Serena Sanna; Myriam Gorospe; David Schlessinger; Edoardo Fiorillo; Magdalena Zoledziewska; Francesco Cucca
Journal:  N Engl J Med       Date:  2017-04-27       Impact factor: 91.245

5.  Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival.

Authors:  Xue Q Liu; Katryn J Stacey; Joshua M Horne-Debets; Jasmyn A Cridland; Katja Fischer; David Narum; Fabienne Mackay; Susan K Pierce; Michelle N Wykes
Journal:  Eur J Immunol       Date:  2012-10-16       Impact factor: 5.532

6.  Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.

Authors:  F Piazza; J C DiFrancesco; M L Fusco; D Corti; L Pirovano; B Frigeni; L Mattavelli; S Andreoni; M Frigo; C Ferrarese; G Tredici; G Cavaletti
Journal:  J Neuroimmunol       Date:  2010-02-11       Impact factor: 3.478

Review 7.  New insights into B cell biology in systemic lupus erythematosus and Sjögren's syndrome.

Authors:  Anna K Bird; Nida Meednu; Jennifer H Anolik
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

Review 8.  B cells and antibodies in multiple sclerosis pathogenesis and therapy.

Authors:  Markus Krumbholz; Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2012-10-09       Impact factor: 42.937

9.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

Authors:  Roberta Magliozzi; Owain Howell; Abhilash Vora; Barbara Serafini; Richard Nicholas; Maria Puopolo; Richard Reynolds; Francesca Aloisi
Journal:  Brain       Date:  2007-04       Impact factor: 13.501

10.  BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma.

Authors:  Markus Krumbholz; Diethilde Theil; Tobias Derfuss; Andreas Rosenwald; Frank Schrader; Camelia-Maria Monoranu; Susan L Kalled; Donna M Hess; Barbara Serafini; Francesca Aloisi; Hartmut Wekerle; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Exp Med       Date:  2005-01-10       Impact factor: 14.307
  10 in total
  1 in total

1.  The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis.

Authors:  Michael Zhong; Anneke van der Walt; Maria Pia Campagna; Jim Stankovich; Helmut Butzkueven; Vilija Jokubaitis
Journal:  Neurotherapeutics       Date:  2020-10-14       Impact factor: 7.620
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.